Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection
- PMID: 22770521
- DOI: 10.1016/j.ijantimicag.2012.04.020
Antibiotic resistance of mixed biofilms in cystic fibrosis: impact of emerging microorganisms on treatment of infection
Abstract
Cystic fibrosis (CF) is a genetic disorder associated with multispecies infections where interactions between classical and newly identified bacteria might be crucial to understanding the persistent colonisation in CF lungs. This study investigated the interactions between two emerging species, Inquilinus limosus and Dolosigranulum pigrum, and the conventional CF pathogen Pseudomonas aeruginosa by evaluating the ability to develop biofilms of mixed populations and then studying their susceptibility patterns to eight different antimicrobials. Monospecies biofilms formed by I. limosus and D. pigrum produced significantly less biomass than P. aeruginosa and displayed greater sensitivity to antimicrobials. However, when in dual-species biofilms with P. aeruginosa, the emerging species I. limosus and D. pigrum were crucial in increasing tolerance of the overall consortia to most antibiotics, even without a change in the number of biofilm-encased cells. These results may suggest that revising these and other species interactions in CF might enable the development of more suitable and effective therapies in the future.
Copyright © 2012 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.
Similar articles
-
Developing a model for cystic fibrosis sociomicrobiology based on antibiotic and environmental stress.Int J Med Microbiol. 2017 Dec;307(8):460-470. doi: 10.1016/j.ijmm.2017.09.018. Epub 2017 Sep 28. Int J Med Microbiol. 2017. PMID: 29033313
-
Quantitative assessment of individual populations within polymicrobial biofilms.Sci Rep. 2018 Jun 22;8(1):9494. doi: 10.1038/s41598-018-27497-9. Sci Rep. 2018. PMID: 29934504 Free PMC article.
-
Emergent bacteria in cystic fibrosis: in vitro biofilm formation and resilience under variable oxygen conditions.Biomed Res Int. 2014;2014:678301. doi: 10.1155/2014/678301. Epub 2014 Apr 29. Biomed Res Int. 2014. PMID: 24868541 Free PMC article.
-
Pseudomonas aeruginosa biofilms in cystic fibrosis.Future Microbiol. 2010 Nov;5(11):1663-74. doi: 10.2217/fmb.10.125. Future Microbiol. 2010. PMID: 21133688 Review.
-
Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.Trends Microbiol. 2009 Mar;17(3):130-8. doi: 10.1016/j.tim.2008.12.003. Epub 2009 Feb 21. Trends Microbiol. 2009. PMID: 19231190 Review.
Cited by
-
Modelling co-infection of the cystic fibrosis lung by Pseudomonas aeruginosa and Burkholderia cenocepacia reveals influences on biofilm formation and host response.PLoS One. 2012;7(12):e52330. doi: 10.1371/journal.pone.0052330. Epub 2012 Dec 21. PLoS One. 2012. PMID: 23284990 Free PMC article.
-
Differential Susceptibility of Mixed Polymicrobial Biofilms Involving Ocular Coccoid Bacteria (Staphylococcus aureus and S. epidermidis) and a Filamentous Fungus (Fusarium solani) on Ex Vivo Human Corneas.Microorganisms. 2023 Feb 6;11(2):413. doi: 10.3390/microorganisms11020413. Microorganisms. 2023. PMID: 36838378 Free PMC article.
-
Borrelia and Chlamydia Can Form Mixed Biofilms in Infected Human Skin Tissues.Eur J Microbiol Immunol (Bp). 2019 Apr 11;9(2):46-55. doi: 10.1556/1886.2019.00003. eCollection 2019 Jun 3. Eur J Microbiol Immunol (Bp). 2019. PMID: 31223496 Free PMC article.
-
Silver oxynitrate, an unexplored silver compound with antimicrobial and antibiofilm activity.Antimicrob Agents Chemother. 2015 Jul;59(7):4031-9. doi: 10.1128/AAC.05177-14. Epub 2015 Apr 27. Antimicrob Agents Chemother. 2015. PMID: 25918137 Free PMC article.
-
Pathogens protection against the action of disinfectants in multispecies biofilms.Front Microbiol. 2015 Jul 14;6:705. doi: 10.3389/fmicb.2015.00705. eCollection 2015. Front Microbiol. 2015. PMID: 26236291 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical